1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. CYMABAY THERAPEUTICS INC

Cymabay Therapeutics Inc

XNAS: CBAY

Momentum Trap

Watchlist

Portfolio

Share


Insider Trading disclosures for Cymabay Therapeutics Inc

The latest disclosure was made by Robert J. Wills in Cymabay Therapeutics Inc where a trade of 25,000 Employee Stock Option (right to buy) done was reported to US exchanges on March 22, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 25,000 0 - - Employee Stock Option (right to buy)
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 25,000 0 - - Employee Stock Option (right to buy)
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 27,000 0 - - Employee Stock Option (right to buy)
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 15,000 0 - - Employee Stock Option (right to buy)
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 7,500 0 - - Employee Stock Option (right to buy)
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 16,000 0 - - Employee Stock Option (right to buy)
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 27,705 0 - - Employee Stock Option (right to buy)
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 49,245 0 - - Employee Stock Option (right to buy)
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 32,000 0 - - Employee Stock Option (right to buy)
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 67,000 0 - - Employee Stock Option (right to buy)
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 18,000 0 - - Employee Stock Option (right to buy)
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 14,010 0 - - Employee Stock Option (right to buy)
Janet Dorling Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 67,000 0 - - Employee Stock Option (right to buy)
Janet Dorling Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 14,010 0 - - Employee Stock Option (right to buy)
Janet Dorling Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 55,000 0 - - Employee Stock Option (right to buy)
Janet Dorling Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 25,000 0 - - Employee Stock Option (right to buy)
Harish Shantharam Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 360,000 0 - - Employee Stock Option (right to buy)
Harish Shantharam Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 74,750 0 - - Employee Stock Option (right to buy)
Harish Shantharam Chief Financial Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 20,125 0 (0%) 0% - Common Stock
Charles A. McWherter President of R&D Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 97,222 0 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 112,000 0 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 225,000 0 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 300,000 0 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 15,000 0 (0%) 0% - Common Stock
Charles A. McWherter President of R&D Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 31,938 0 (0%) 0% - Common Stock
Charles A. McWherter President of R&D Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 91,666 0 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 51,750 0 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 44,084 0 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 118,625 0 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 146,875 0 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 172,891 0 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 328,299 0 - - Employee Stock Option (right to buy)
Eric Lefebvre Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 25,000 0 - - Employee Stock Option (right to buy)
Eric Lefebvre Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 14,010 0 - - Employee Stock Option (right to buy)
Eric Lefebvre Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 115,000 0 - - Employee Stock Option (right to buy)
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 9,000 0 - - Employee Stock Option (right to buy)
Robert J. Wills Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 30,000 0 (0%) 0% - Common Stock
Klara A. Dickinson Chief Regulatory Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 66,500 0 - - Employee Stock Option (right to buy)
Klara A. Dickinson Chief Regulatory Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 328,299 0 - - Employee Stock Option (right to buy)
Klara A. Dickinson Chief Regulatory Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 138,312 0 - - Employee Stock Option (right to buy)
Klara A. Dickinson Chief Regulatory Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 100,000 0 - - Employee Stock Option (right to buy)
Klara A. Dickinson Chief Regulatory Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 200,000 0 - - Employee Stock Option (right to buy)
Klara A. Dickinson Chief Regulatory Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 21,000 0 (0%) 0% - Common Stock
Klara A. Dickinson Chief Regulatory Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 78,000 0 - - Employee Stock Option (right to buy)
Klara A. Dickinson Chief Regulatory Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 215,000 0 - - Employee Stock Option (right to buy)
Klara A. Dickinson Chief Regulatory Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 175,000 0 - - Employee Stock Option (right to buy)
Kurt von Emster Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 9,000 0 - - Employee Stock Option (right to buy)
Kurt von Emster Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 9,000 0 - - Employee Stock Option (right to buy)
Kurt von Emster Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 9,000 0 - - Employee Stock Option (right to buy)
Kurt von Emster Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 14,010 0 - - Employee Stock Option (right to buy)
Kurt von Emster Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 90,000 0 (0%) 0% - Common Stock
Kurt von Emster Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 25,000 0 - - Employee Stock Option (right to buy)
Kurt von Emster Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 67,000 0 - - Employee Stock Option (right to buy)
Kurt von Emster Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 32,000 0 - - Employee Stock Option (right to buy)
Kurt von Emster Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 49,245 0 - - Employee Stock Option (right to buy)
Kurt von Emster Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 27,705 0 - - Employee Stock Option (right to buy)
Kurt von Emster Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 16,000 0 - - Employee Stock Option (right to buy)
Kurt von Emster Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 7,500 0 - - Employee Stock Option (right to buy)
Kurt von Emster Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 15,000 0 - - Employee Stock Option (right to buy)
Thomas G. Wiggans Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 25,000 0 - - Employee Stock Option (right to buy)
Thomas G. Wiggans Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 80,000 0 - - Employee Stock Option (right to buy)
Thomas G. Wiggans Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 67,000 0 - - Employee Stock Option (right to buy)
Thomas G. Wiggans Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 14,010 0 - - Employee Stock Option (right to buy)
Caroline M. Loewy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 15,000 0 - - Employee Stock Option (right to buy)
Caroline M. Loewy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 14,010 0 - - Employee Stock Option (right to buy)
Caroline M. Loewy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 25,000 0 - - Employee Stock Option (right to buy)
Caroline M. Loewy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 67,000 0 - - Employee Stock Option (right to buy)
Caroline M. Loewy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 32,000 0 - - Employee Stock Option (right to buy)
Caroline M. Loewy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 49,245 0 - - Employee Stock Option (right to buy)
Caroline M. Loewy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 27,705 0 - - Employee Stock Option (right to buy)
Caroline M. Loewy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 16,000 0 - - Employee Stock Option (right to buy)
Caroline M. Loewy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 7,500 0 - - Employee Stock Option (right to buy)
Caroline M. Loewy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 30,000 0 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 105,625 0 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 215,000 0 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 107,000 0 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 22,167 0 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 233,176 0 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 28,438 0 (0%) 0% - Common Stock
Paul T. Quinlan General Counsel Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 41,824 0 (0%) 0% - Common Stock
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 621,101 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 90,000 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 47,916 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 50,000 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 39,375 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 88,351 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 96,250 0 (0%) 0% - Common Stock
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 310,420 0 (0%) 0% - Common Stock
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 357,500 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 800,000 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 649,999 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 284,712 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 536,032 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 314,120 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 22 Mar 2024 146,875 0 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2024 41,824 8,872 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.89 per share. 13 Mar 2024 41,824 70,262 (0%) 0% 7.9 329,991 Common Stock
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2024 2,288 12,845 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2024 22,076 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2024 14,372 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2024 3,125 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2024 18,899 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2024 52,084 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2024 14,625 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2024 11,649 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. 13 Mar 2024 1 406,670 (0%) 0% 3 3 Common Stock
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.78 per share. 13 Mar 2024 2,288 406,669 (0%) 0% 5.8 13,225 Common Stock
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.05 per share. 13 Mar 2024 22,076 404,381 (0%) 0% 4.1 89,408 Common Stock
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.43 per share. 13 Mar 2024 14,372 382,305 (0%) 0% 8.4 121,156 Common Stock
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Mar 2024 1 35,799 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.69 per share. 13 Mar 2024 3,125 367,933 (0%) 0% 11.7 36,531 Common Stock
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.21 per share. 13 Mar 2024 18,899 364,808 (0%) 0% 9.2 174,060 Common Stock
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.72 per share. 13 Mar 2024 52,084 345,909 (0%) 0% 1.7 89,584 Common Stock
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 13 Mar 2024 14,625 293,825 (0%) 0% 1.1 15,503 Common Stock
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. 13 Mar 2024 11,649 279,200 (0%) 0% 10 116,490 Common Stock
Janet Dorling Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Feb 2024 6,000 55,000 - - Employee Stock Option (right to buy)
Janet Dorling Director Sale of securities on an exchange or to another person at price $ 31.97 per share. 12 Feb 2024 6,000 0 (0%) 0% 32.0 191,849 Common Stock
Dorling Janet Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. 12 Feb 2024 6,000 6,000 (0%) 0% 4.6 27,780 Common Stock
Quinlan T. Paul General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 28,438 28,438 (0%) 0% 0 Common Stock
A. Klara Dickinson Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 21,000 21,000 (0%) 0% 0 Common Stock
Charles McWherter A. President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 31,938 46,938 (0%) 0% 0 Common Stock
Harish Shantharam Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 20,125 20,125 (0%) 0% 0 Common Stock
Shantharam Harish Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 74,750 74,750 - - Employee Stock Option (right to buy)
Loewy M. Caroline Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 14,010 14,010 - - Stock Option (right to buy)
Eric Lefebvre Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 14,010 14,010 - - Stock Option (right to buy)
Thomas G. Wiggans Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 14,010 14,010 - - Stock Option (right to buy)
Shah Sujal Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 96,250 267,551 (0%) 0% 0 Common Stock
von Emster Kurt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 14,010 14,010 - - Stock Option (right to buy)
Klara Dickinson A. Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 78,000 78,000 - - Employee Stock Option (right to buy)
Wills Robert J. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 14,010 14,010 - - Stock Option (right to buy)
T. Quinlan Paul General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 105,625 105,625 - - Employee Stock Option (right to buy)
Shah Sujal Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 357,500 357,500 - - Employee Stock Option (right to buy)
A. McWherter Charles President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 118,625 118,625 - - Employee Stock Option (right to buy)
Dorling Janet Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2024 14,010 14,010 - - Stock Option (right to buy)
Charles A. McWherter President of R&D Sale of securities on an exchange or to another person at price $ 23.68 per share. 19 Jan 2024 3,125 15,000 (0%) 0% 23.7 73,988 Common Stock
McWherter Charles A. President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jan 2024 8,334 91,666 - - Employee Stock Option (right to buy)
A. McWherter Charles President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jan 2024 1,916 44,084 - - Employee Stock Option (right to buy)
A. McWherter Charles President of R&D Sale of securities on an exchange or to another person at price $ 23.67 per share. 19 Jan 2024 2,250 15,000 (0%) 0% 23.7 53,262 Common Stock
Charles McWherter A. President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jan 2024 2,250 51,750 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jan 2024 2,778 97,222 - - Employee Stock Option (right to buy)
A. Charles McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 19 Jan 2024 2,250 17,250 (0%) 0% 1.1 2,385 Common Stock
A. McWherter Charles President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.69 per share. 19 Jan 2024 3,125 18,125 (0%) 0% 11.7 36,531 Common Stock
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.82 per share. 19 Jan 2024 1,916 16,916 (0%) 0% 1.8 3,487 Common Stock
A. McWherter Charles President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.72 per share. 19 Jan 2024 2,778 17,778 (0%) 0% 1.7 4,778 Common Stock
Charles McWherter A. President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. 19 Jan 2024 8,334 23,334 (0%) 0% 10 83,340 Common Stock
McWherter A. Charles President of R&D Sale of securities on an exchange or to another person at price $ 23.66 per share. 19 Jan 2024 1,916 15,000 (0%) 0% 23.7 45,340 Common Stock
A. Charles McWherter President of R&D Sale of securities on an exchange or to another person at price $ 23.68 per share. 19 Jan 2024 8,334 15,000 (0%) 0% 23.7 197,316 Common Stock
McWherter Charles A. President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Jan 2024 3,125 146,875 - - Employee Stock Option (right to buy)
McWherter Charles A. President of R&D Sale of securities on an exchange or to another person at price $ 23.66 per share. 19 Jan 2024 2,778 15,000 (0%) 0% 23.7 65,739 Common Stock
Quinlan T. Paul General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. 16 Jan 2024 5,000 5,000 (0%) 0% 2.9 14,700 Common Stock
Quinlan T. Paul General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jan 2024 5,000 107,000 - - Employee Stock Option (right to buy)
T. Paul Quinlan General Counsel Sale of securities on an exchange or to another person at price $ 23.58 per share. 16 Jan 2024 5,000 0 (0%) 0% 23.6 117,898 Common Stock
Daniel Menold Vice President, Finance Sale of securities on an exchange or to another person at price $ 23.58 per share. 16 Jan 2024 10,000 0 (0%) 0% 23.6 235,806 Common Stock
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.05 per share. 16 Jan 2024 10,000 10,000 (0%) 0% 4.1 40,500 Common Stock
Menold Daniel Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jan 2024 10,000 135,109 - - Employee Stock Option (right to buy)
Dorling Janet Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jan 2024 6,000 61,000 - - Employee Stock Option (right to buy)
Dorling Janet Director Sale of securities on an exchange or to another person at price $ 23.86 per share. 10 Jan 2024 6,000 0 (0%) 0% 23.9 143,144 Common Stock
Janet Dorling Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. 10 Jan 2024 6,000 6,000 (0%) 0% 4.6 27,780 Common Stock
Charles A. McWherter President of R&D Sale of securities on an exchange or to another person at price $ 21.48 per share. 18 Dec 2023 6,504 15,000 (0%) 0% 21.5 139,703 Common Stock
McWherter Charles A. President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 18 Dec 2023 6,504 21,504 (0%) 0% 5 32,520 Common Stock
McWherter A. Charles President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Dec 2023 3,890 0 - - Employee Stock Option (right to buy)
McWherter Charles A. President of R&D Sale of securities on an exchange or to another person at price $ 21.49 per share. 18 Dec 2023 4,828 15,000 (0%) 0% 21.5 103,738 Common Stock
McWherter Charles A. President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Dec 2023 6,504 0 - - Employee Stock Option (right to buy)
McWherter Charles A. President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 18 Dec 2023 4,828 19,828 (0%) 0% 5 24,140 Common Stock
McWherter A. Charles President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Dec 2023 704 0 - - Employee Stock Option (right to buy)
McWherter A. Charles President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Dec 2023 234 0 - - Employee Stock Option (right to buy)
Quinlan T. Paul General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. 15 Dec 2023 5,000 5,000 (0%) 0% 2.9 14,700 Common Stock
Menold Daniel Vice President, Finance Sale of securities on an exchange or to another person at price $ 21.98 per share. 15 Dec 2023 10,000 0 (0%) 0% 22.0 219,847 Common Stock
Paul T. Quinlan General Counsel Sale of securities on an exchange or to another person at price $ 21.98 per share. 15 Dec 2023 5,000 0 (0%) 0% 22.0 109,903 Common Stock
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.43 per share. 15 Dec 2023 11,497 11,497 (0%) 0% 8.4 96,920 Common Stock
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2023 10,000 145,109 - - Employee Stock Option (right to buy)
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2023 11,497 0 - - Employee Stock Option (right to buy)
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.05 per share. 15 Dec 2023 10,000 10,000 (0%) 0% 4.1 40,500 Common Stock
Daniel Menold Vice President, Finance Sale of securities on an exchange or to another person at price $ 21.99 per share. 15 Dec 2023 11,497 0 (0%) 0% 22.0 252,799 Common Stock
Paul Quinlan T. General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Dec 2023 5,000 112,000 - - Employee Stock Option (right to buy)
Dorling Janet Director Sale of securities on an exchange or to another person at price $ 20.07 per share. 11 Dec 2023 6,000 0 (0%) 0% 20.1 120,422 Common Stock
Shah Sujal Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 19.99 per share. 11 Dec 2023 63,975 171,301 (0%) 0% 20.0 1,278,649 Common Stock
Janet Dorling Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2023 6,000 67,000 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2023 12,973 0 - - Stock Appreciation Right
Shah Sujal Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2023 31,036 0 - - Employee Stock Option (right to buy)
Shah Sujal Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 11 Dec 2023 63,975 235,276 (0%) 0% 5 319,875 Common Stock
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Dec 2023 20,856 0 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 11 Dec 2023 890 172,191 (0%) 0% 5 4,450 Common Stock
Janet Dorling Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.63 per share. 11 Dec 2023 6,000 6,000 (0%) 0% 4.6 27,780 Common Stock
Shah Sujal Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 20.81 per share. 11 Dec 2023 890 171,301 (0%) 0% 20.8 18,521 Common Stock
Paul T. Quinlan General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. 15 Aug 2023 5,000 5,000 (0%) 0% 2.9 14,700 Common Stock
Paul T. Quinlan General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2023 5,000 180,000 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Sale of securities on an exchange or to another person at price $ 11.91 per share. 15 Aug 2023 5,000 0 (0%) 0% 11.9 59,551 Common Stock
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. 15 Aug 2023 7,000 7,000 (0%) 0% 10 70,000 Common Stock
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.06 per share. 15 Aug 2023 8,500 8,500 (0%) 0% 1.1 9,010 Common Stock
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2023 7,000 0 - - Employee Stock Option (right to buy)
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2023 8,500 0 - - Employee Stock Option (right to buy)
Daniel Menold Vice President, Finance Sale of securities on an exchange or to another person at price $ 12.35 per share. 09 Aug 2023 20,945 0 (0%) 0% 12.4 258,744 Common Stock
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Aug 2023 6,486 0 - - Stock Appreciation Right
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Aug 2023 14,459 0 - - Employee Stock Option (right to buy)
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 09 Aug 2023 20,945 20,945 (0%) 0% 5 104,725 Common Stock
Charles A. McWherter President of R&D Sale of securities on an exchange or to another person at price $ 11.43 per share. 18 Jul 2023 21,749 15,000 (0%) 0% 11.4 248,519 Common Stock
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jul 2023 6,506 32,528 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jul 2023 3,892 19,458 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jul 2023 236 1,178 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jul 2023 708 3,536 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jul 2023 10,407 31,209 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 18 Jul 2023 21,749 36,749 (0%) 0% 5 108,745 Common Stock
Paul T. Quinlan General Counsel Sale of securities on an exchange or to another person at price $ 11.81 per share. 14 Jul 2023 5,000 0 (0%) 0% 11.8 59,050 Common Stock
Paul T. Quinlan General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jul 2023 5,000 185,000 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. 14 Jul 2023 5,000 5,000 (0%) 0% 2.9 14,700 Common Stock
Paul T. Quinlan General Counsel Sale of securities on an exchange or to another person at price $ 10.05 per share. 30 Jun 2023 5,000 0 (0%) 0% 10.1 50,250 Common Stock
Paul T. Quinlan General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2023 5,000 190,000 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. 30 Jun 2023 5,000 5,000 (0%) 0% 2.9 14,700 Common Stock
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 20 Jun 2023 21,749 36,749 (0%) 0% 5 108,745 Common Stock
Charles A. McWherter President of R&D Sale of securities on an exchange or to another person at price $ 8.16 per share. 20 Jun 2023 21,749 15,000 (0%) 0% 8.2 177,383 Common Stock
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jun 2023 10,407 41,616 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jun 2023 708 4,244 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jun 2023 236 1,414 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jun 2023 3,892 23,350 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Jun 2023 6,506 39,034 - - Employee Stock Option (right to buy)
Harish Shantharam Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2023 360,000 360,000 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2023 6,506 45,540 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2023 3,892 27,242 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2023 236 1,650 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2023 708 4,952 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 May 2023 10,407 52,023 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 18 May 2023 21,749 36,749 (0%) 0% 5 108,745 Common Stock
Charles A. McWherter President of R&D Sale of securities on an exchange or to another person at price $ 9.08 per share. 18 May 2023 21,749 15,000 (0%) 0% 9.1 197,387 Common Stock
Paul T. Quinlan General Counsel Sale of securities on an exchange or to another person at price $ 10.37 per share. 15 May 2023 5,000 0 (0%) 0% 10.4 51,831 Common Stock
Paul T. Quinlan General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 May 2023 5,000 195,000 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. 15 May 2023 5,000 5,000 (0%) 0% 2.9 14,700 Common Stock
Dennis D. Kim Chief Medical Officer Sale of securities on an exchange or to another person at price $ 8.98 per share. 13 Apr 2023 7,781 20,000 (0%) 0% 9.0 69,880 Common Stock
Dennis D. Kim Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Apr 2023 112,219 169,900 - - Employee Stock Option (right to buy)
Dennis D. Kim Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Apr 2023 7,781 282,119 - - Employee Stock Option (right to buy)
Dennis D. Kim Chief Medical Officer Sale of securities on an exchange or to another person at price $ 9.54 per share. 13 Apr 2023 112,219 20,000 (0%) 0% 9.5 1,070,536 Common Stock
Dennis D. Kim Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.37 per share. 13 Apr 2023 112,219 132,219 (0%) 0% 4.4 490,397 Common Stock
Dennis D. Kim Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.37 per share. 13 Apr 2023 7,781 27,781 (0%) 0% 4.4 34,003 Common Stock
Dennis D. Kim Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Mar 2023 100 289,900 - - Employee Stock Option (right to buy)
Dennis D. Kim Chief Medical Officer Sale of securities on an exchange or to another person at price $ 8.99 per share. 28 Mar 2023 100 20,000 (0%) 0% 9.0 899 Common Stock
Dennis D. Kim Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.37 per share. 28 Mar 2023 100 20,100 (0%) 0% 4.4 437 Common Stock
Klara A. Dickinson Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 215,000 215,000 - - Employee Stock Option (right to buy)
Kurt von Emster Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 25,000 25,000 - - Stock Option (right to buy)
Thomas G. Wiggans Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 25,000 25,000 - - Stock Option (right to buy)
Caroline M. Loewy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 25,000 25,000 - - Stock Option (right to buy)
Lewis J. Stuart Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 215,000 215,000 - - Employee Stock Option (right to buy)
Dennis D. Kim Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 180,000 180,000 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 215,000 215,000 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 800,000 800,000 - - Employee Stock Option (right to buy)
Charles A. McWherter President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 300,000 300,000 - - Employee Stock Option (right to buy)
Eric Lefebvre Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 25,000 25,000 - - Stock Option (right to buy)
Robert J. Wills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 25,000 25,000 - - Stock Option (right to buy)
Daniel Menold Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 100,000 100,000 - - Employee Stock Option (right to buy)
Janet Dorling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2023 25,000 25,000 - - Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.95 per share. 06 Jun 2022 51,301 171,301 (0%) 0% 2.0 100,037 Common Stock
Eric Lefebvre Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2022 115,000 115,000 - - Stock Option (right to buy)
Klara A. Dickinson Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 175,000 175,000 - - Employee Stock Option (right to buy)
Kurt von Emster Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 67,000 67,000 - - Stock Option (right to buy)
Caroline M. Loewy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 67,000 67,000 - - Stock Option (right to buy)
Lewis J. Stuart Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 116,667 116,667 - - Employee Stock Option (right to buy)
Dennis D. Kim Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 133,333 133,333 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 200,000 200,000 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 650,000 650,000 - - Employee Stock Option (right to buy)
Charles A. McWherter Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 225,000 225,000 - - Employee Stock Option (right to buy)
Robert J. Wills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 67,000 67,000 - - Stock Option (right to buy)
Daniel Menold Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 75,000 75,000 - - Employee Stock Option (right to buy)
Janet Dorling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2022 67,000 67,000 - - Stock Option (right to buy)
Dennis D. Kim Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 3.04 per share. 19 Jan 2022 20,000 20,000 (0%) 0% 3.0 60,800 Common Stock
Janet Dorling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2021 80,000 80,000 - - Stock Option (right to buy)
Klara A. Dickinson Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2021 66,500 66,500 - - Employee Stock Option (right to buy)
Kurt von Emster Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2021 32,000 32,000 - - Stock Option (right to buy)
Caroline M. Loewy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2021 32,000 32,000 - - Stock Option (right to buy)
Paul F. Truex Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2021 32,000 32,000 - - Stock Option (right to buy)
Paul T. Quinlan General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2021 22,167 22,167 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2021 287,000 287,000 - - Employee Stock Option (right to buy)
Charles A. McWherter Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2021 112,000 112,000 - - Employee Stock Option (right to buy)
Robert J. Wills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2021 32,000 32,000 - - Stock Option (right to buy)
Daniel Menold Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2021 42,000 42,000 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Oct 2020 275,000 275,000 - - Employee Stock Option (right to buy)
Klara A. Dickinson See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 328,299 328,299 - - Stock Option (Right to Buy)
Kurt von Emster Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 49,245 49,245 - - Stock Option (Right to Buy)
Kurt von Emster Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 49,245 49,245 - - Stock Option (Right to Buy)
Caroline M. Loewy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 49,245 49,245 - - Stock Option (Right to Buy)
Paul F. Truex Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 49,245 49,245 - - Stock Option (Right to Buy)
Sujal Shah Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 558,108 558,108 - - Stock Option (Right to Buy)
Charles A. McWherter SVP & Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 328,299 328,299 - - Stock Option (Right to Buy)
Robert J. Wills Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 49,245 49,245 - - Stock Option (Right to Buy)
Daniel Menold Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 May 2020 180,564 180,564 - - Stock Option (Right to Buy)
Sujal Shah Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 4.30 per share. 10 Oct 2019 5,000 120,000 (0%) 0% 4.3 21,500 Common Stock
Sujal Shah Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 5.50 per share. 20 Sep 2019 1,900 111,900 (0%) 0% 5.5 10,450 Common Stock
Sujal Shah Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 5.55 per share. 20 Sep 2019 3,100 115,000 (0%) 0% 5.6 17,205 Common Stock
Janet Dorling Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2019 341,000 341,000 - - Employee Stock Option (right to buy)
Carl S. Goldfischer None Sale of securities on an exchange or to another person at price $ 9.02 per share. 07 Feb 2019 11,675 0 (0%) 0% 9.0 105,328 Common Stock
Carl S. Goldfischer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Feb 2019 2,335 0 - - Stock Option (right to buy)
Carl S. Goldfischer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. 07 Feb 2019 9,340 11,675 (0%) 0% 5.5 51,370 Common Stock
Carl S. Goldfischer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 07 Feb 2019 2,335 2,335 (0%) 0% 5 11,675 Common Stock
Carl S. Goldfischer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Feb 2019 9,340 0 - - Stock Option (right to buy)
Klara A. Dickinson Chief Regulatory Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 138,312 138,312 - - Employee Stock Option (right to buy)
Kurt von Emster None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 27,705 27,705 - - Stock option (right to buy)
Robert F.G Booth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 27,705 27,705 - - Stock Option (right to buy)
Caroline M. Loewy None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 27,705 27,705 - - Stock Option (right to buy)
Carl S. Goldfischer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 27,705 27,705 - - Stock Option (right to buy)
Pol F. Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 138,312 138,312 - - Employee Stock Option (right to buy)
Paul F. Truex None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 27,705 27,705 - - Stock Option (right to buy)
Paul T. Quinlan General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 86,445 86,445 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 328,492 328,492 - - Employee Stock Option (right to buy)
Charles A. McWherter Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 172,891 172,891 - - Employee Stock Option (right to buy)
Evan A. Stein None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 27,705 27,705 - - Stock Option (right to buy)
Robert J. Wills None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 27,705 27,705 - - Stock Option (right to buy)
Robert J. Weiland None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 27,705 27,705 - - Stock Option (right to buy)
Daniel Menold Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2019 69,156 69,156 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 6.54 per share. 21 Dec 2018 10,000 110,000 (0%) 0% 6.5 65,399 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 7.43 per share. 17 Dec 2018 53,492 131,036 (0%) 0% 7.4 397,365 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 8.17 per share. 17 Dec 2018 88,889 184,528 (0%) 0% 8.2 726,223 Common Stock
Sujal Shah Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 9.90 per share. 15 Oct 2018 5,000 100,000 (0%) 0% 9.9 49,500 Common Stock
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Aug 2018 5,000 14,459 - - Employee Stock Option (right to buy)
Daniel Menold Vice President, Finance Sale of securities on an exchange or to another person at price $ 13.00 per share. 29 Aug 2018 5,000 0 (0%) 0% 13 65,000 Common Stock
Daniel Menold Vice President, Finance Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 29 Aug 2018 5,000 5,000 (0%) 0% 5 25,000 Common Stock
Sujal Shah Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 10.90 per share. 27 Jul 2018 5,000 95,000 (0%) 0% 10.9 54,500 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 12.51 per share. 05 Jun 2018 920 18,316 (0%) 0% 12.5 11,509 Common Stock
Kurt von Emster None 05 Jun 2018 2,000 0 - - Warrant (right to buy)
Kurt von Emster None 05 Jun 2018 2,000 19,236 (0%) 0% 5.8 11,500 Common Stock
Carl S. Goldfischer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Mar 2018 2,870 0 - - Stock Option (right to buy)
Carl S. Goldfischer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.00 per share. 22 Mar 2018 9,340 9,340 (0%) 0% 5 46,700 Common Stock
Carl S. Goldfischer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.50 per share. 22 Mar 2018 5,660 15,000 (0%) 0% 5.5 31,130 Common Stock
Carl S. Goldfischer None Sale of securities on an exchange or to another person at price $ 13.02 per share. 22 Mar 2018 15,000 0 (0%) 0% 13.0 195,375 Common Stock
Carl S. Goldfischer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Mar 2018 5,660 9,340 - - Stock Option (right to buy)
Carl S. Goldfischer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Mar 2018 6,470 0 - - Stock Option (right to buy)
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 15.51 per share. 05 Mar 2018 13,353 273,417 (0%) 0% 15.5 207,105 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 14.49 per share. 15 Feb 2018 68,712 286,770 (0%) 0% 14.5 995,637 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 13.69 per share. 14 Feb 2018 162,979 355,482 (0%) 0% 13.7 2,231,183 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 12.35 per share. 07 Feb 2018 40,763 419,693 (0%) 0% 12.3 503,423 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 12.14 per share. 05 Feb 2018 18,831 460,456 (0%) 0% 12.1 228,608 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 12.15 per share. 01 Feb 2018 88,098 481,287 (0%) 0% 12.2 1,070,391 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 12.11 per share. 01 Feb 2018 2,000 479,287 (0%) 0% 12.1 24,220 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 12.23 per share. 30 Jan 2018 12,300 569,385 (1%) 0% 12.2 150,429 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 12.22 per share. 30 Jan 2018 85,339 581,685 (1%) 0% 12.2 1,042,843 Common Stock
Klara A. Dickinson SVP, Regulatory and Quality Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 100,000 100,000 - - Employee Stock Option (right to buy)
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 12.18 per share. 24 Jan 2018 39,438 667,024 (1%) 0% 12.2 480,355 Common Stock
Kurt von Emster None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 16,000 16,000 - - Stock Option (right to buy)
Robert F.G Booth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 16,000 16,000 - - Stock Option (right to buy)
Caroline M. Loewy None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 16,000 16,000 - - Stock Option (right to buy)
Carl S. Goldfischer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 16,000 16,000 - - Stock Option (right to buy)
Pol F. Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 125,000 125,000 - - Employee Stock Option (right to buy)
Paul F. Truex None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 16,000 16,000 - - Stock Option (right to buy)
Paul T. Quinlan General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 250,000 250,000 - - Employee Stock Option (right to buy)
Paul T. Quinlan General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 50,000 50,000 - - Employee Stock Option (right to buy)
Sujal Shah Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 150,000 150,000 - - Employee Stock Option (right to buy)
Charles A. McWherter Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 150,000 150,000 - - Employee Stock Option (right to buy)
Robert L. Martin SVP, Nonclinical & Manuf. Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 125,000 125,000 - - Employee Stock Option (right to buy)
Patrick J. O’Mara SVP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 125,000 125,000 - - Employee Stock Option (right to buy)
Evan A. Stein None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 16,000 16,000 - - Stock Option (right to buy)
Robert J. Wills None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 16,000 16,000 - - Stock Option (right to buy)
Robert J. Weiland None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 16,000 16,000 - - Stock Option (right to buy)
Daniel Menold Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jan 2018 62,500 62,500 - - Employee Stock Option (right to buy)
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 10.40 per share. 22 Jan 2018 138,253 706,462 (1%) 0% 10.4 1,437,831 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 10.21 per share. 18 Jan 2018 13,632 975,299 (2%) 0% 10.2 139,183 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 10.25 per share. 18 Jan 2018 130,584 844,715 (1%) 0% 10.3 1,338,486 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 10.21 per share. 05 Jan 2018 4,300 988,931 (2%) 0% 10.2 43,903 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 9.41 per share. 22 Dec 2017 173,192 993,231 (2%) 0% 9.4 1,629,304 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 9.26 per share. 10 Nov 2017 50,048 1,166,423 (2%) 0% 9.3 463,379 Common Stock
Carl S. Goldfischer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.97 per share. 02 Nov 2017 9,000 18,000 (0%) 0% 3.0 26,730 Common Stock
Carl S. Goldfischer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Nov 2017 9,000 0 - - Stock Option (right to buy)
Carl S. Goldfischer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Nov 2017 9,000 0 - - Stock Option (right to buy)
Carl S. Goldfischer None Sale of securities on an exchange or to another person at price $ 8.66 per share. 02 Nov 2017 18,000 0 (0%) 0% 8.7 155,880 Common Stock
Carl S. Goldfischer None Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.72 per share. 02 Nov 2017 9,000 9,000 (0%) 0% 1.7 15,480 Common Stock
Charles A. McWherter SVP & Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 8.67 per share. 02 Nov 2017 300 10,300 (0%) 0% 8.7 2,601 Common Stock
Charles A. McWherter SVP & Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 8.67 per share. 02 Nov 2017 4,700 15,000 (0%) 0% 8.7 40,740 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 9.25 per share. 01 Nov 2017 4,320 1,216,471 (2%) 0% 9.3 39,979 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 9.27 per share. 30 Oct 2017 52,573 1,220,791 (2%) 0% 9.3 487,352 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 9.26 per share. 30 Oct 2017 6,636 1,273,364 (2%) 0% 9.3 61,449 Common Stock
Sujal Shah Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Oct 2017 640,000 640,000 - - Stock Option (right to buy)
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 7.81 per share. 02 Oct 2017 70,940 1,280,000 (2%) 0% 7.8 554,041 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 7.93 per share. 02 Oct 2017 37,936 1,350,940 (3%) 0% 7.9 300,832 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 8.15 per share. 28 Sep 2017 90,389 1,509,611 (3%) 0% 8.1 736,670 Common Stock
Kurt von Emster None Sale of securities on an exchange or to another person at price $ 8.04 per share. 28 Sep 2017 120,735 1,388,876 (3%) 0% 8.0 970,709 Common Stock
Kurt von Emster None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2017 7,500 7,500 - - Stock Option (right to buy)
Robert F.G Booth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2017 7,500 7,500 - - Stock Option (right to buy)
Caroline M. Loewy None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2017 7,500 7,500 - - Stock Option (right to buy)
Carl S. Goldfischer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2017 7,500 7,500 - - Stock Option (right to buy)
Paul F. Truex None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2017 7,500 7,500 - - Stock Option (right to buy)
Evan A. Stein None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2017 7,500 7,500 - - Stock Option (right to buy)
Robert J. Wills None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2017 7,500 7,500 - - Stock Option (right to buy)
Robert J. Weiland None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2017 7,500 7,500 - - Stock Option (right to buy)
Robert J. Wills None Purchase of securities on an exchange or from another person at price $ 6.83 per share. 01 Aug 2017 200 25,200 (0%) 0% 6.8 1,366 Common Stock
Robert J. Wills None Purchase of securities on an exchange or from another person at price $ 6.84 per share. 01 Aug 2017 300 25,500 (0%) 0% 6.8 2,051 Common Stock
Robert J. Wills None Purchase of securities on an exchange or from another person at price $ 6.84 per share. 01 Aug 2017 1,000 26,500 (0%) 0% 6.8 6,839 Common Stock
Robert J. Wills None Purchase of securities on an exchange or from another person at price $ 6.85 per share. 01 Aug 2017 3,500 30,000 (0%) 0% 6.8 23,965 Common Stock
Sujal Shah Director, Interim President & CEO Purchase of securities on an exchange or from another person at price $ 7.35 per share. 20 Jul 2017 8,033 85,000 (0%) 0% 7.4 59,043 Common Stock
Sujal Shah Director, Interim President & CEO Purchase of securities on an exchange or from another person at price $ 7.29 per share. 20 Jul 2017 891 75,891 (0%) 0% 7.3 6,495 Common Stock
Sujal Shah Director, Interim President & CEO Purchase of securities on an exchange or from another person at price $ 7.30 per share. 20 Jul 2017 400 76,291 (0%) 0% 7.3 2,920 Common Stock
Sujal Shah Director, Interim President & CEO Purchase of securities on an exchange or from another person at price $ 7.31 per share. 20 Jul 2017 576 76,867 (0%) 0% 7.3 4,211 Common Stock
Sujal Shah Director, Interim President & CEO Purchase of securities on an exchange or from another person at price $ 7.32 per share. 20 Jul 2017 100 76,967 (0%) 0% 7.3 732 Common Stock
Charles A. McWherter SVP & Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 7.43 per share. 20 Jul 2017 3,000 8,100 (0%) 0% 7.4 22,280 Common Stock
Charles A. McWherter SVP & Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 7.43 per share. 20 Jul 2017 1,700 10,000 (0%) 0% 7.4 12,629 Common Stock
Charles A. McWherter SVP & Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 7.43 per share. 20 Jul 2017 200 8,300 (0%) 0% 7.4 1,486 Common Stock
Charles A. McWherter SVP & Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 7.42 per share. 20 Jul 2017 100 5,100 (0%) 0% 7.4 742 Common Stock
Kurt von Emster None Purchase of securities on an exchange or from another person at price $ 6.50 per share. 19 Jul 2017 153,846 1,753,846 (6%) 0% 6.5 999,999 Common Stock
Klara A. Dickinson SVP, Regulatory Affairs & QA Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2017 200,000 200,000 - - Stock Option (right to buy)
Kurt von Emster None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
Robert F.G Booth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
Caroline M. Loewy None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
Carl S. Goldfischer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
Paul F. Truex None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
Evan A. Stein None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
Robert J. Wills None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
Robert J. Weiland None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2017 15,000 15,000 - - Stock Option (right to buy)
Daniel Menold Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2017 35,000 35,000 - - Stock Option (right to buy)
Sujal Shah Interim CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2017 90,000 90,000 - - Employee Stock Option (right to buy)
Robert J. Wills None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2017 27,000 27,000 - - Stock Option (right to buy)
Robert F.G Booth None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2017 30,000 30,000 - - Stock Option (right to buy)
Caroline M. Loewy None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2017 30,000 30,000 - - Stock Option (right to buy)
Pol F. Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2017 100,000 100,000 - - Employee Stock Option (right to buy)
Paul F. Truex None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2017 12,000 12,000 - - Stock Option (right to buy)
Harold E. Van Wart Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2017 200,000 200,000 - - Employee Stock Option (right to buy)
Sujal Shah Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2017 100,000 100,000 - - Employee Stock Option (right to buy)
Charles A. McWherter Sr. Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2017 100,000 100,000 - - Employee Stock Option (right to buy)
Robert L. Martin Sr. Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2017 100,000 100,000 - - Employee Stock Option (right to buy)
Patrick J. O’Mara SVP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2017 100,000 100,000 - - Employee Stock Option (right to buy)
Evan A. Stein None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2017 12,000 12,000 - - Stock Option (right to buy)
Kirk Rosemark V.P. Regulatory & Quality Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2017 50,000 50,000 - - Employee Stock Option (right to buy)
Robert J. Weiland None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2017 12,000 12,000 - - Stock Option (right to buy)
Harold E. Van Wart Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2017 50,000 100,000 - - Employee Stock Option (right to buy)
Sujal Shah Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2017 25,000 50,000 - - Employee Stock Option (right to buy)
Charles A. McWherter Sr. Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2017 23,000 46,000 - - Employee Stock Option (right to buy)
Robert L. Martin Sr. Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2017 21,000 42,000 - - Employee Stock Option (right to buy)
Patrick J. O’Mara VP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2017 12,500 25,000 - - Employee Stock Option (right to buy)
Kirk Rosemark V.P. Regulatory & Quality Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2017 11,000 22,000 - - Employee Stock Option (right to buy)
Pol F. Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2016 21,000 21,000 - - Employee Stock Option (right to buy)
Harold E. Van Wart Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2016 50,000 50,000 - - Employee Stock Option (right to buy)
Sujal Shah Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2016 25,000 25,000 - - Employee Stock Option (right to buy)
Charles A. McWherter Sr. Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2016 23,000 23,000 - - Employee Stock Option (right to buy)
Robert L. Martin Sr. Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2016 21,000 21,000 - - Employee Stock Option (right to buy)
Patrick J. O’Mara VP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2016 12,500 12,500 - - Employee Stock Option (right to buy)
Kirk Rosemark V.P. Regulatory & Quality Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Dec 2016 11,000 11,000 - - Employee Stock Option (right to buy)
Robert J. Wills None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Sep 2016 25,000 25,000 - - Common Stock
Carl S. Goldfischer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2016 9,000 9,000 - - Stock Option (right to buy)
Kurt von Emster None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2016 9,000 9,000 - - Stock Option (right to buy)
Robert J. Wills None Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jun 2016 9,000 9,000 - - Stock Option (right to buy)
Paul F. Truex None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2016 18,000 18,000 - - Stock Option (right to buy)
Evan A. Stein None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2016 18,000 18,000 - - Stock Option (right to buy)
Robert J. Weiland None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2016 18,000 18,000 - - Stock Option (right to buy)
Charles A. McWherter Sr. Vice President Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Apr 2016 3,000 5,000 - - Common Stock
Patrick J. O’Mara VP, Business Development Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 Apr 2016 5,000 5,022 - - Common Stock
Sujal Shah Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Apr 2016 33,000 75,000 - - Common Stock
Sujal Shah Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Apr 2016 22,000 42,000 - - Common Stock
Pol F. Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2016 54,000 54,000 - - Employee Stock Option (right to buy)
Harold E. Van Wart Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2016 157,500 157,500 - - Employee Stock Option (right to buy)
Sujal Shah Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2016 54,000 54,000 - - Employee Stock Option (right to buy)
Charles A. McWherter Sr. Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2016 54,000 54,000 - - Employee Stock Option (right to buy)
Robert L. Martin Sr. Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2016 54,000 54,000 - - Employee Stock Option (right to buy)
Patrick J. O’Mara VP, Business Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2016 27,000 27,000 - - Employee Stock Option (right to buy)
Kirk Rosemark V.P. Regulatory & Quality Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2016 18,419 18,419 - - Employee Stock Option (right to buy)
Robert J. Wills None Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Oct 2015 25,000 25,000 - - Stock Option (right to buy)
Carl S. Goldfischer None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Sep 2015 905 1,959 - - Common Stock
Carl S. Goldfischer None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Sep 2015 13,844 29,980 - - Common Stock
Carl S. Goldfischer None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Sep 2015 15 13 - - Common Stock
Carl S. Goldfischer None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Sep 2015 1,011 948 - - Common Stock
Carl S. Goldfischer None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Sep 2015 13 0 - - Common Stock
Carl S. Goldfischer None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Sep 2015 13 28 - - Common Stock
Carl S. Goldfischer None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Sep 2015 948 0 - - Common Stock
Carl S. Goldfischer None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Sep 2015 14,506 0 - - Common Stock
Carl S. Goldfischer None Sale of securities on an exchange or to another person at price $ 0.00 per share. 09 Sep 2015 15,474 14,506 - - Common Stock
Kurt von Emster None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Aug 2015 31,359 31,359 - - Common Stock
Kurt von Emster None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Aug 2015 58,641 90,000 - - Common stock
Kurt von Emster None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 20 Jul 2015 1,600,000 1,600,000 - - Common Stock
Louis G. Lange None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2015 9,000 9,000 - - Stock Option (right to buy)
Carl S. Goldfischer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2015 9,000 9,000 - - Stock Option (right to buy)
Kurt von Emster None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2015 9,000 9,000 - - Stock Option (right to buy)
Hari Kumar None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2015 9,000 9,000 - - Stock Option (right to buy)
Kirk Rosemark V.P. Regulatory & Quality Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jun 2015 37,500 37,500 - - Stock Option (right to buy)
Harold E. Van Wart Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 May 2015 100 7,858 - - Common Stock
Harold E. Van Wart Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 May 2015 100 7,958 - - Common Stock
Harold E. Van Wart Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 May 2015 7,300 7,758 - - Common Stock
Sujal Shah Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 18 May 2015 10,000 20,000 - - Common Stock
Charles A. McWherter Sr. Vice President Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 May 2015 600 1,000 - - Common Stock
Charles A. McWherter Sr. Vice President Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 May 2015 400 400 - - Common Stock
Charles A. McWherter Sr. Vice President Purchase of securities on an exchange or from another person at price $ 0.00 per share. 15 May 2015 1,000 2,000 - - Common Stock
Robert J. Wills None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Apr 2015 18,000 18,000 - - Stock Option (right to buy)
Louis G. Lange None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2015 9,000 9,000 - - Stock Option (right to buy)
Carl S. Goldfischer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2015 9,000 9,000 - - Stock Option (right to buy)
Edward E. Penhoet None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2015 9,000 9,000 - - Stock Option (right to buy)
Kurt von Emster None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2015 9,000 9,000 - - Stock Option (right to buy)
Pol F. Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2015 75,000 75,000 - - Stock Option (right to buy)
Harold E. Van Wart Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2015 180,000 180,000 - - Stock Option (right to buy)
Sujal Shah Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2015 100,000 100,000 - - Stock Option (right to buy)
Charles A. McWherter Sr. Vice President Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2015 100,000 100,000 - - Stock Option (right to buy)
Hari Kumar None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2015 9,000 9,000 - - Stock Option (right to buy)
Sujal Shah Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Sep 2014 10,000 10,000 - - Common Stock
Pol F. Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2014 77,000 77,000 - - Stock Option (right to buy)
Pol F. Boudes Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2014 26,000 26,000 - - Stock Appreciation Right
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters